1Pitt B; Segal R, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure[J]. Lancet,1997,349: 742- 752.
2Crozier I; Kram H. Losartan in heart failure hemodynamic effects and tolerability [ J ]. Circulation, 1995,91: 691- 697.
3Kabour A; Hengar JR. Prevention of angiotention induced myocyte necrosis and coronary vasocular damage by lisinpril and losartan [ J ]. Cardiovascular Reseach, 1995, 29:543 -548.
4Basu S, Senior R, et al. Beneficial effects of intravenous and oral carvedilol tretment in acute myocardial infarction. a placebo- controlled, randomized trial [ J ]. Circulation, 1997,96:183-191.
5Brunvand H, Kvitting PM. Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms [J ].Journal Cardiovascular Pharmacology, 1996,28: 409- 417.
6Yue TL,Chen HY. Carvedilol, a new vasodilator and betaadrenoveptor antagonist, is an antioxidant and free radical scavenger[J ]. J Pharmcal Exp Ther 1992,263: 97- 98.
